Endocrinology · Hyperprolactinemia
The facts most likely to be tested
The initial evaluation for galactorrhea requires a serum prolactin level, TSH, and a pregnancy test to rule out common secondary causes.
Prolactinoma is the most common pituitary adenoma and typically presents with bilateral milky nipple discharge and amenorrhea in women.
Dopamine antagonists, such as antipsychotics (e.g., risperidone) and metoclopramide, are the most common medication-induced causes of hyperprolactinemia.
Hypothyroidism causes galactorrhea via increased thyrotropin-releasing hormone (TRH), which stimulates lactotrophs to secrete excess prolactin.
MRI of the pituitary gland with contrast is the gold standard imaging modality to confirm the presence of a prolactinoma.
Dopamine agonists, specifically cabergoline or bromocriptine, are the first-line medical treatment for symptomatic prolactinomas.
Physiologic galactorrhea is typically bilateral and multiductal, whereas pathologic nipple discharge is often unilateral, spontaneous, and bloody.
Vignette unlocked
A 28-year-old woman presents to the clinic complaining of bilateral milky nipple discharge for the past three months. She also reports oligomenorrhea and occasional headaches. Her physical examination reveals bilateral galactorrhea on breast expression, but no palpable masses or skin changes. Her serum pregnancy test is negative, and her TSH is within normal limits.
What is the most appropriate next step in the management of this patient?
Serum prolactin level
The patient presents with classic signs of hyperprolactinemia; after ruling out pregnancy and hypothyroidism, the next step is to measure prolactin to confirm the diagnosis and guide further imaging.
Full handout
High yield triage
Etiology / Epidemiology
Commonly caused by prolactinoma, hypothyroidism, or medications. Evaluate for pregnancy in all reproductive-age women.
Clinical Manifestations
Bilateral, milky nipple discharge unrelated to breastfeeding. Look for amenorrhea and bitemporal hemianopsia.
Diagnosis
Order serum prolactin and TSH. MRI of the pituitary is the gold standard for suspected adenoma.
Treatment
Treat underlying cause. Use cabergoline or bromocriptine for symptomatic prolactinoma. Avoid pregnancy if untreated.
Prognosis
Most cases are benign. 90% respond to dopamine agonists; monitor for visual field deficits.
Full handout
Epidemiology & Etiology
Galactorrhea is most frequently associated with hyperprolactinemia. Primary etiologies include pituitary adenomas, hypothyroidism (due to elevated TRH), and medication-induced dopamine blockade. Always exclude pregnancy via serum hCG as the initial step in any patient of childbearing age.
Pertinent Anatomy
The hypothalamic-pituitary axis regulates prolactin via tonic inhibition by dopamine. The pituitary gland sits within the sella turcica, where mass effects can compress the optic chiasm.
Pathophysiology
Dopamine acts as the primary prolactin-inhibiting factor. Disruption of this pathway—whether by prolactin-secreting tumors, dopamine antagonists, or stalk compression—leads to disinhibition of lactotroph cells. Elevated prolactin levels suppress gonadotropin-releasing hormone (GnRH) pulsatility, resulting in secondary hypogonadism.
Clinical Manifestations
Patients present with bilateral, non-bloody, milky discharge. Associated symptoms include amenorrhea, infertility, and decreased libido. Red flags include unilateral discharge, bloody discharge, or a palpable breast mass, which necessitate imaging to rule out breast cancer.
Diagnosis
Initial workup includes serum prolactin, TSH, and hCG. A prolactin level >200 ng/mL is highly suggestive of a prolactinoma. MRI of the pituitary is the gold standard to visualize microadenomas (<10mm) or macroadenomas (>10mm).
Treatment
Discontinue offending medications if possible. For symptomatic prolactinomas, cabergoline is the preferred dopamine agonist due to superior efficacy and tolerability. Bromocriptine is an alternative but has a higher side-effect profile. Surgery is reserved for patients who are refractory to medical therapy or have acute vision loss.
Prognosis
Most patients achieve normalization of prolactin and resolution of symptoms with medical therapy. Long-term monitoring of visual fields and prolactin levels is required. Macroadenomas carry a higher risk of permanent hypopituitarism.
Differential Diagnosis
Prolactinoma: elevated prolactin with mass effect symptoms
Hypothyroidism: elevated TSH and TRH stimulating prolactin
Medication-induced: history of antipsychotic or metoclopramide use
Intraductal papilloma: unilateral, bloody nipple discharge
Pregnancy: positive serum hCG